Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging

Summary

This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population

Timeline

Start

2020-12-01

Primary completion

2025-12-05

Completion

2025-12-05

Drugs

Indications